The bankruptcy of genetic-testing pioneer 23andMe is a powerful cautionary tale. After going public in 2021 with a $3.5 billion valuation, the company’s market cap plummeted to less than $13.5 million ...
In Destiny’s Child No Longer: Rewriting Genetic Fate, we envisioned a world where every newborn would be screened for genetic risks. We see a future in which the randomness of genetic inheritance ...
Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more individualized care, including changes in medication, referrals to clinical ...
A child inherits around 35 percent to 40 percent of their body mass index from their parents, according to a study published in Economics and Human Biology. The research team, headed by the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback